Neumora Therapeutics, Inc. (NMRA) Discusses Positive Phase 1b Results for NMRA-511 in Alzheimer's Disease Agitation Transcript
Neumora Therapeutics(US:NMRA) Seeking Alpha·2026-01-05 18:28PresentationLadies and gentlemen, thank you for standing by. [Operator Instructions] Please be advised that today's event is being recorded. I would now like to turn the call over to Helen Rubinstein, Vice President, Investor Relations and Communications at Neumora. Please go ahead.Helen RubinsteinHead of Investor Relations Good morning, everyone, and thank you for joining us today to discuss top line data from the Phase Ib signal-seeking study with NMRA-511 in Alzheimer's disease agitation. Before we begin ...